|
|
||||||||
CONCISE REVIEW |
a Immunology Program, Child Health Research Institute, North Adelaide, South Australia, Australia;
b Haematology Division, Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, South Australia, Australia;
c Department of Paediatrics, University of Adelaide, Adelaide, South Australia, Australia
Key Words. Hematopoietic stem cells (HSCs) • Cytokines • Hematopoietic development • Umbilical cord blood • Ex vivo expansion
Correspondence: Richard DAndrea, Ph.D., Child Health Research Institute, 72 King William Road, North Adelaide, South Australia, 5006, Australia. Telephone: 61-8-8161-8105; Fax: 61-8-8239-0267; e-mail: Richard.dandrea{at}adelaide.edu.au
Blood formation occurs throughout the life of an individual in a process driven by hematopoietic stem cells (HSCs). The ability of bone marrow (BM) and cord blood (CB) HSC to undergo self-renewal and develop into multiple blood lineages has made these cells an important clinical resource. Transplantation with BM- and CB-derived HSCs is now used extensively for treatment of hematological disorders, malignancies, and immunodeficiencies. An understanding of the embryonic origin of HSC and the factors regulating their generation and expansion in vivo will provide important information for the manipulation of these cells ex vivo. This is critical for the further development of CB transplantation, the potential of which is limited by small numbers of HSC in the donorpopulation.
Although the origins of HSCs have become clearerand progress has been made in identifying genes that are critical for the formation and maintenance of HSCs, less is known about the signals that commit specific populations of mesodermal precursors to hematopoietic cell fate. Critical signals acting on these precursorcells are likely to be derived from visceral endoderm in yolk sac and from underlying stroma in the aorta-gonadmesonephros region. Here we summarize briefly the origin of yolk sac and embryonic HSCs before detailing evidence that bone morphogenic protein-4 (BMP4) has a crucial role in Xenopus and mammalian HSC development. We discuss evidence that BMP4 acts as a hematopoietic growth factor and review its potential to modulate HSC in ex vivo expansion cultures from cord blood.
This article has been cited by other articles:
![]() |
S. Noda, K. Horiguchi, H. Ichikawa, and H. Miyoshi Repopulating Activity of Ex Vivo-Expanded Murine Hematopoietic Stem Cells Resides in the CD48-c-Kit+Sca-1+Lineage Marker- Cell Population Stem Cells, March 1, 2008; 26(3): 646 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. McReynolds, S. Gupta, M. E. Figueroa, M. C. Mullins, and T. Evans Smad1 and Smad5 differentially regulate embryonic hematopoiesis Blood, December 1, 2007; 110(12): 3881 - 3890. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. A. Mikkola and S. H. Orkin The journey of developing hematopoietic stem cells. Development, October 1, 2006; 133(19): 3733 - 3744. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hua, Y.-Q. Zhang, S. Dabernat, M. Kritzik, D. Dietz, L. Sterling, and N. Sarvetnick BMP4 Regulates Pancreatic Progenitor Cell Expansion through Id2 J. Biol. Chem., May 12, 2006; 281(19): 13574 - 13580. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
